Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK

Author： Halekotte Jakob   Witt Lydia   Ianes Chiara   Krüger Marc   Bührmann Mike   Rauh Daniel   Pichlo Christian   Brunstein Elena   Luxenburger Andreas   Baumann Ulrich   Knippschild Uwe   Bischof Joachim   Peifer Christian  

Publisher： MDPI

E-ISSN： 1420-3049|22|4|522-522

ISSN： 1420-3049

Source： Molecules, Vol.22, Iss.4, 2017-03, pp. : 522-522

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Diverse and Versatile Regiospecific Synthesis of Tetrasubstituted Alkylsulfanylimidazoles as p38α Mitogen-Activated Protein Kinase Inhibitors

By Ansideri Francesco   Andreev Stanislav   Kuhn Annette   Albrecht Wolfgang   Laufer Stefan A.   Koch Pierre  

Molecules, Vol. 23, Iss. 1, 2018-01 ,pp. : 221-221

MDPI

Access to resources Recommend Favorite

3D-QSAR and Molecular Docking Studies on Fused Pyrazoles as p38α Mitogen-Activated Protein Kinase Inhibitors

By Lan Ping   Huang Zhi-Jian   Sun Jun-Rong   Chen Wei-Min  

International Journal of Molecular Sciences, Vol. 11, Iss. 9, 2010-09 ,pp. : 3357-3374

MDPI

Access to resources Recommend Favorite

Structural Determinants of CX-4945 Derivatives as Protein Kinase CK2 Inhibitors: A Computational Study

By Liu Hongbo   Wang Xia   Wang Jian   Wang Jinghui   Li Yan   Yang Ling   Li Guohui  

International Journal of Molecular Sciences, Vol. 12, Iss. 10, 2011-10 ,pp. : 7004-7021

MDPI

Access to resources Recommend Favorite

A π-Halogen Bond of Dibenzofuranones with the Gatekeeper Phe113 in Human Protein Kinase CK2 Leads to Potent Tight Binding Inhibitors

By Schnitzler Alexander   Gratz Andreas   Bollacke Andre   Weyrich Michael   Kuckländer Uwe   Wünsch Bernhard   Götz Claudia   Niefind Karsten   Jose Joachim  

Pharmaceuticals, Vol. 11, Iss. 1, 2018-02 ,pp. : 23-23

MDPI

Access to resources Recommend Favorite

Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome

By Bagley Mark C.   Davis Terence   Murziani Paola G. S.   Widdowson Caroline S.   Kipling David  

Pharmaceuticals, Vol. 3, Iss. 6, 2010-06 ,pp. : 1842-1872

MDPI

Access to resources Recommend Favorite